– USA, MA – Sengenics Corporation LLC, driving the discovery of next-gen biomarkers today announced the appointment of Dr. Yvonne Linney (Ph.D.) to its Board of Directors, effective immediately.
“We welcome Dr. Linney to the Board as a new independent Director and look forward to the leadership she will bring. We are pleased to add her deep knowledge in life science markets and her breadth of expertise leading both private and public companies to the Board,” said Board Chairman, Dr. Nick Roelofs.
About Dr. Yvonne Linney
With more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products, Dr. Yvonne Linney promises to help build on Sengenics’ growth in the fields of immunology, immuno-oncology, neurological disease, and precision medicine.
Dr. Linney is a proven business leader who has successfully brought emerging technologies to market and grown their adoption in the life science markets. She has previously held executive roles at Agilent Technologies (A) Life Sciences Group and Amersham International (GE Healthcare), as well as more recently CEO and COO roles at venture-based companies, Transcriptic and Artificial Inc. She is also a member of the Board of Directors of Bionano Genomics Inc.
“Sengenics is an early pioneer in autoantibody detection for life science research, drug development, and precision medicine,” said Dr. Yvonne Linney. “It is an exciting time for the Company, and I am eager to be part of the team as they continue to address the significant unmet medical needs of patients suffering from cancer, autoimmune disease, and neurological disorders through their premier immuno-proteomic platform, KREX.”
About Sengenics
Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, therapeutic response prediction, and the development of companion diagnostics. Sengenics Corporation LLC is headquartered in Greater Boston, Massachusetts, USA, and has offices worldwide.
For more information: https://sengenics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
